Literature DB >> 9100037

The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure.

I Martinez1, R Saracho, J Montenegro, F Llach.   

Abstract

Secondary hyperparathyroidism (HPT) was evaluated in 157 patients with chronic renal failure (CRF). It was noted that HPT developed early in CRF at a time when plasma calcium and phosphorous were within normal limits. As creatinine clearance decreased below 80 mL/m, there was a significant decrease in plasma calcitriol and a slow and progressive significant increment in plasma parathyroid hormone (PTH). The effect of dietary intake of calcium and phosphorous was evaluated in these patients with early renal failure (ERF). They were divided into two groups. Group A was placed on a protein- and phosphorous-restricted diet (10 days) followed by a daily phosphorous-load diet (10 days). Group B had similar sequential diets plus a calcium supplement throughout the study. Dietary protein and phosphorous restriction resulted in an amelioration of the HPT only in the group of patients receiving calcium supplementation. The phosphate-load diet resulted in worsening of HPT in both groups. In summary, a deficit of calcitriol occurs early in CRF, which in turn leads to a significant increase in PTH. Phosphorous restriction, together with calcium supplementation, ameliorated the HPT of patients with ERF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9100037     DOI: 10.1016/s0272-6386(97)90330-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  31 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  Chronic renal disease.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2002-07-13

Review 3.  Guidelines for the management of chronic kidney disease.

Authors:  Adeera Levin; Brenda Hemmelgarn; Bruce Culleton; Sheldon Tobe; Philip McFarlane; Marcel Ruzicka; Kevin Burns; Braden Manns; Colin White; Francoise Madore; Louise Moist; Scott Klarenbach; Brendan Barrett; Robert Foley; Kailash Jindal; Peter Senior; Neesh Pannu; Sabin Shurraw; Ayub Akbari; Adam Cohn; Martina Reslerova; Vinay Deved; David Mendelssohn; Gihad Nesrallah; Joanne Kappel; Marcello Tonelli
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

Review 4.  Diseases of the parathyroid gland in chronic kidney disease.

Authors:  Hirotaka Komaba; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

Review 5.  Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride.

Authors:  Desmond Padhi; Robert Harris
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 6.  New therapies: calcimimetics, phosphate binders and vitamin D receptor activators.

Authors:  Jorge B Cannata-Andía; Minerva Rodriguez-García; Pablo Román-García; Diego Tuñón-le Poultel; Francisco López-Hernández; Diego Rodríguez-Puyol
Journal:  Pediatr Nephrol       Date:  2010-02-12       Impact factor: 3.714

Review 7.  Normocalcemic primary hyperparathyroidism.

Authors:  Natalie E Cusano; Shonni J Silverberg; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

8.  Associations between serum leptin level and bone turnover in kidney transplant recipients.

Authors:  Csaba P Kovesdy; Miklos Z Molnar; Maria E Czira; Anna Rudas; Akos Ujszaszi; Laszlo Rosivall; Miklos Szathmari; Adrian Covic; Andras Keszei; Gabriella Beko; Peter Lakatos; Janos Kosa; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

Review 9.  Inorganic phosphate homeostasis and the role of dietary phosphorus.

Authors:  Eiji Takeda; Hironori Yamamoto; Kunitaka Nashiki; Tadatoshi Sato; Hidekazu Arai; Yutaka Taketani
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

10.  A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min.

Authors:  Laurent C Dukas; Erich Schacht; Ze'ev Mazor; Hannes B Stähelin
Journal:  Osteoporos Int       Date:  2004-07-08       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.